Fig. 2From: Presymptomatic treatment of classic late-infantile neuronal ceroid lipofuscinosis with cerliponase alfaGross motor function measure-66 (GMFM-66) total scores in patient 1 (bullets) and patient 2 (boxes) during two years of treatment with cerliponase alfa. Dotted lines represent 95% confidence intervalsBack to article page